Rosalind Eeles
Professor Eeles is both a clinician and scientist and has been instrumental in ensuring new discoveries in cancer genetics immediately benefit patients, particularly in her speciality areas of genetic predisposition to prostate cancer from rare and common constitutional genomic variation.
She trained at the University of Cambridge and St Thomas’ Hospital Medical School, has a PhD in cancer genetics and is a fellow of the Royal College of Physicians of London and the Royal College of Radiologists (Clinical Oncology Faculty). She is also the Genomics Champion for The Royal College of Radiologists (Clinical Oncology Faculty).
She leads the largest prostate cancer genetic study in the UK, set up an international consortium that involves over 100 research groups worldwide, and is leading multiple clinical trials and screening studies. She also started the flagship, Prostate Risk clinic at the RMH to evaluate the increasing role of genetic testing in men with and at risk of prostate cancer.
She has sat on many genetics advisory committees, both national and international. She is author on over 500 papers and her book which she led as lead editor ‘Cancer Prevention and Screening’ won the BMA Chairman’s Book of the Year Award in 2019.
She jointly leads the Early Detection and Diagnosis virtual centre at The Royal Marsden Hospital and The Institute of Cancer Research.
Sessions
-
Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study27-Jan-2027Cancer Diagnostics Stage